Name | amorolfine |
---|---|
Synonyms |
(±)-cis-2,6-Dimethyl-4-(2-methyl-3-(p-tert-pentylphenyl)propyl)morpholine
(±)-cis-2,6-Dimethyl-4-[2-methyl-3-(p-tert-pentylphenyl)propyl]morpholine Ro-l4-4767/000 4-(3-(4-(1,1-Dimethylpropyl)phenyl)-2-methylpropyl)-2,6-dimethylmorpholine Loceryl amorolfin cis-4-{3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propyl}-2,6-dimethylmorpholine (2R,6S)-2,6-Dimethyl-4-{2-methyl-3-[4-(2-methyl-2-butanyl)phenyl]propyl}morpholine (2R,6S)-2,6-Dimethyl-4-{2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl}morpholine Ro 14-4767/000 Morpholine, 4-[3-[4-(1,1-dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethyl-, (2R,6S)- MFCD00865597 cis-4-[3-[4-(1,1-Dimethylpropyl)phenyl]-2-methylpropyl]-2,6-dimethylmorpholine (+/-)-cis-2,6-dimethyl-4-[2-methyl-3-(p-tert-pentylphenyl)propyl]morpholine Amorolfine Ro 14-4767 SYLIMARIN |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 407.1±33.0 °C at 760 mmHg |
Melting Point | 134ºC |
Molecular Formula | C21H35NO |
Molecular Weight | 317.509 |
Flash Point | 119.6±27.7 °C |
Exact Mass | 317.271851 |
PSA | 12.47000 |
LogP | 5.73 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.489 |
Hazard Codes | Xn |
---|---|
Risk Phrases | 20/21/22-36/37/38 |
Safety Phrases | S26-S36 |
~% 78613-35-1 |
Literature: US2011/301346 A1, ; Page/Page column 5-6 ; |
~% 78613-35-1 |
Literature: EP1935889 A1, ; Page/Page column 8-9 ; |
~8% 78613-35-1 |
Literature: GALDERMA S.A. Patent: WO2007/12983 A2, 2007 ; Location in patent: Page/Page column 13-16 ; |
~0% 78613-35-1 |
Literature: GALDERMA S.A. Patent: WO2007/12983 A2, 2007 ; Location in patent: Page/Page column 13-16 ; |
~% 78613-35-1 |
Literature: EP1935889 A1, ; Page/Page column 8-9 ; |
Precursor 3 | |
---|---|
DownStream 0 |